D236 Comprehensive Medical Conditions Outline

Grace J.
November 11, 2025November 11, 2025
BSN, D236, Western Governors University

Student Name

Western Governors University

D236 Pathophysiology

Prof. Name

Date

Rhabdomyolysis

Rhabdomyolysis is a pathological condition characterized by the breakdown of skeletal muscle fibers, leading to the release of intracellular substances such as myoglobin into the bloodstream. Myoglobin, when present in large amounts, imposes a significant burden on the kidneys, which attempt to filter it through the nephrons. However, the toxicity of myoglobin to renal tubular cells can precipitate acute tubular necrosis, resulting in acute kidney injury (AKI) (Huerta-Alardín, Varon, & Marik, 2005).

Clinical Manifestations of Rhabdomyolysis

Patients typically present with a triad comprising muscle pain (myalgia), generalized weakness, and dark-colored urine due to myoglobinuria. However, it is important to note that over 50% of individuals may lack muscle pain or weakness, and the earliest indication might be discoloration of urine, often described as tea-colored (Torres et al., 2021).

Diagnostic Criteria and Laboratory Findings

The most reliable laboratory marker for rhabdomyolysis is an elevated serum creatine kinase (CK) level. A CK value exceeding five times the normal upper limit strongly supports the diagnosis. It is essential to exclude cardiac or neurological causes of elevated CK to confirm skeletal muscle origin (Melli, Chaudhry, & Cornblath, 2005).

Clinical Finding	Description
Myalgia	Diffuse muscle soreness and pain
Weakness	Reduced muscle strength and fatigue
Myoglobinuria	Dark (tea or cola) colored urine due to myoglobin excretion
Elevated CK	Serum CK elevated >5 times the upper normal limit indicating muscle injury
Complication	Acute kidney injury resulting from myoglobin nephrotoxicity

Phagocytosis

What is Phagocytosis?

Phagocytosis is an essential immune process in which specialized cells such as neutrophils and macrophages engulf and destroy invading pathogens or foreign particles. This process involves sequential stages: recognition of the target, attachment, engulfment, and intracellular digestion. During engulfment, the cell membrane extends pseudopods around the target to form a phagosome. Lysosomes then merge with the phagosome, releasing degradative enzymes and reactive oxygen species that eliminate the ingested material (Underhill & Goodridge, 2012).

Stage	Process Description
Recognition & Attachment	Leukocytes detect and bind foreign material
Engulfment	Pseudopods surround and internalize the target
Phagosome Formation	Creation of an intracellular vesicle containing the engulfed particle
Digestion	Lysosomal enzymes degrade or kill the target

Ovarian Cancer

Ovarian cancer is notorious for its silent progression, often showing few early symptoms. This underscores the significance of biomarker testing for early diagnosis. Two primary biomarkers, CA-125 and Human Epididymis Protein 4 (HE4), are extensively utilized for detection and monitoring.

CA-125, a glycoprotein, tends to be elevated in epithelial ovarian cancers but can also be raised in benign gynecological conditions. HE4 is more specific to ovarian malignancies. Combining these markers using the Risk of Ovarian Malignancy Algorithm (ROMA) enhances diagnostic precision (Moore et al., 2008).

Biomarker	Clinical Use
CA-125	Used for screening and monitoring ovarian cancer progression
HE4	Improves specificity in ovarian cancer detection
ROMA Index	Algorithm combining CA-125 and HE4 to estimate malignancy risk

Hypospadias

Hypospadias is a congenital deformity in males where the urethral opening is misplaced on the underside (ventral aspect) of the penis rather than at the tip. The severity ranges from mild (subcoronal) to severe (perineal). It is a common birth defect in males and can interfere with normal urination and fertility due to abnormal semen deposition. Surgical repair during infancy is the standard treatment aimed at restoring function and appearance (Carmichael et al., 2013).

Hypogonadism and Cryptorchidism

Definitions

Hypogonadism refers to inadequate testosterone production or sperm generation by the testes. Cryptorchidism, or undescended testes, occurs when one or both testes fail to descend into the scrotum before birth. These conditions are prevalent congenital abnormalities in newborn males.

Cryptorchidism is particularly concerning due to its association with increased risks of infertility and testicular cancer later in life. Early surgical intervention, usually orchiopexy before the age of two, is recommended to mitigate these risks (Kolon et al., 2014).

Condition	Description	Complications
Hypogonadism	Low testosterone or sperm production	Infertility, delayed puberty
Cryptorchidism	Failure of testis descent into scrotum	Infertility, testicular cancer risk

Appendicitis

Appendicitis is an acute inflammatory condition of the appendix often caused by obstruction from fecaliths, lymphoid hyperplasia, or foreign objects. It is a surgical emergency to prevent complications such as perforation or peritonitis.

Clinical Presentation

Patients initially experience peri-umbilical pain that later localizes to the right lower quadrant (RLQ), especially at McBurney’s point. Associated symptoms include nausea, vomiting, anorexia, mild fever, and chills. Movement, coughing, or deep breathing tends to exacerbate the pain (Addiss, Shaffer, Fowler, & Tauxe, 1990).

Symptom	Description
Abdominal Pain	Starts around the umbilicus, moves to RLQ
Nausea and Vomiting	Usually follows abdominal pain
Fever and Chills	Mild to moderate, indicating inflammation
Anorexia	Loss of appetite
Constipation/Diarrhea	Sometimes present, with abdominal bloating

Physical Examination Signs

Sign	Procedure	Positive Interpretation
Psoas Sign	Patient flexes right thigh against resistance while supine	RLQ pain due to psoas muscle irritation
Rovsing’s Sign	Palpation of left lower quadrant	RLQ pain suggests appendiceal inflammation
Rebound Tenderness	Deep abdominal palpation followed by rapid release	Sharp pain indicating peritoneal irritation
Obturator Sign	Flexion and rotation of right hip	RLQ pain from obturator muscle irritation
Guarding	Involuntary abdominal muscle contraction	Suggests peritoneal irritation

Untreated appendicitis can lead to life-threatening complications like bowel perforation and peritonitis. Surgical appendectomy remains the treatment of choice, usually preceded by antibiotic therapy.

Peptic Ulcer Disease

Peptic ulcer disease (PUD) involves the development of open sores on the inner lining of the stomach or the proximal part of the duodenum. These ulcers result from an imbalance between aggressive factors such as gastric acid and pepsin and protective mechanisms including mucus production and bicarbonate secretion.

Etiology and Risk Factors

The most common cause of PUD is infection with Helicobacter pylori bacteria, which damages the mucosal lining and triggers inflammation. Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) is another significant contributor by impairing prostaglandin synthesis, thereby reducing mucosal protection. Additional risk factors include smoking, excessive alcohol use, stress, and genetic predisposition (Sung et al., 2009).

Clinical Presentation

Patients often report epigastric pain described as burning or gnawing, which may improve or worsen with food intake. Complications include bleeding, perforation, and gastric outlet obstruction.

Symptom	Description
Epigastric Pain	Burning pain aggravated by fasting or at night
Nausea and Vomiting	May accompany ulcer symptoms
Hematemesis or Melena	Vomiting blood or black tarry stools indicating bleeding
Weight Loss	Secondary to chronic symptoms and anorexia

Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by continuous mucosal inflammation of the colon, primarily affecting the rectum and extending proximally. Unlike Crohn’s disease, UC involves only the mucosal layer.

Pathophysiology and Symptoms

The inflammation leads to ulceration, bleeding, and impaired absorption. Patients commonly experience bloody diarrhea, abdominal cramping, and urgency. The disease follows a relapsing and remitting course, often with systemic symptoms such as fever and weight loss during flares (Ordás, Eckmann, Talamini, Baumgart, & Sandborn, 2012).

Clinical Feature	Typical Presentation
Bloody Diarrhea	Frequent stools with blood and mucus
Abdominal Pain	Cramping, usually in the lower abdomen
Tenesmus	Urgency and feeling of incomplete evacuation
Extraintestinal Manifestations	Arthritis, skin lesions, and eye inflammation

Asthma

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchial hyperresponsiveness. It is driven by an exaggerated immune response to allergens or irritants.

Symptoms and Pathophysiology

Common symptoms include episodic wheezing, shortness of breath, chest tightness, and coughing, especially at night or early morning. The underlying pathophysiology involves airway inflammation, mucus hypersecretion, and bronchospasm triggered by exposure to allergens or irritants (GINA, 2023).

Symptom	Characteristic Features
Wheezing	High-pitched expiratory sounds
Dyspnea	Difficulty breathing, often episodic
Cough	Persistent, sometimes dry or productive
Chest Tightness	Sensation of constriction or pressure

Bronchiectasis

Bronchiectasis is a chronic condition defined by irreversible dilatation and destruction of the bronchial walls, resulting in impaired mucociliary clearance and recurrent infections.

Causes and Clinical Features

It may result from repeated infections, cystic fibrosis, immunodeficiencies, or congenital abnormalities. Patients often present with chronic productive cough, copious purulent sputum, hemoptysis, and recurrent respiratory infections (King, 2009).

Symptom	Clinical Relevance
Chronic Cough	Persistent productive cough
Sputum Production	Large volumes of purulent sputum
Hemoptysis	Coughing up blood due to bronchial wall damage
Recurrent Infections	Frequent episodes of pneumonia or bronchitis

Chronic Bronchitis

Chronic bronchitis, a subtype of chronic obstructive pulmonary disease (COPD), is characterized by chronic inflammation of the bronchi, leading to mucus hypersecretion and productive cough lasting at least three months for two consecutive years.

Clinical Presentation

Patients typically complain of a daily productive cough, dyspnea on exertion, and frequent respiratory infections. Smoking is the leading cause, contributing to airway inflammation and mucus gland hypertrophy (GOLD, 2024).

Feature	Description
Chronic Cough	Productive cough lasting >3 months
Dyspnea	Shortness of breath with exertion
Frequent Infections	Exacerbations often triggered by infections
Cyanosis	Late sign of hypoxemia (“blue bloater”)

Emphysema

Emphysema is another subtype of COPD characterized by destruction of alveolar walls and enlargement of air spaces distal to terminal bronchioles. This results in impaired gas exchange and loss of elastic recoil.

Causes and Symptoms

Smoking is the primary cause, but alpha-1 antitrypsin deficiency is a genetic risk factor. Patients often present with progressive dyspnea, minimal cough, and a barrel-shaped chest. Unlike chronic bronchitis, they tend to be “pink puffers,” maintaining relatively normal oxygen levels until late stages (Celli & MacNee, 2004).

Characteristic	Description
Dyspnea	Progressive shortness of breath
Minimal Cough	Compared to chronic bronchitis
Barrel Chest	Increased anteroposterior chest diameter
Pursed-Lip Breathing	Helps improve ventilation

Asthma vs COPD

Feature	Asthma	COPD
Age of Onset	Often childhood or early adulthood	Middle-aged or older adults
Reversibility	Mostly reversible airway obstruction	Partially reversible or irreversible
Inflammation Type	Eosinophilic, allergic	Neutrophilic, related to smoking
Symptoms	Episodic wheezing and cough	Chronic cough, sputum, and progressive dyspnea
Triggers	Allergens, exercise, cold air	Smoking, pollution, infections

References

Celli, B. R., & MacNee, W. (2004). Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal, 23(6), 932–946.

Global Initiative for Asthma (GINA). (2023). Global strategy for asthma management and prevention. Retrieved from https://ginasthma.org

Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Retrieved from https://goldcopd.org

King, P. T. (2009). The pathophysiology of bronchiectasis. International Journal of Chronic Obstructive Pulmonary Disease, 4, 411–419.

Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012). Ulcerative colitis. The Lancet, 380(9853), 1606–1619.

Sung, J. J., Kuipers, E. J., & El-Serag, H. B. (2009). Systematic review: the global incidence and prevalence of peptic ulcer disease. Alimentary Pharmacology & Therapeutics, 29(9), 938–946.

Addiss, D. G., Shaffer, N., Fowler, B. S., & Tauxe, R. V. (1990). The epidemiology of appendicitis and appendectomy in the United States. American Journal of Epidemiology, 132(5), 910–925.

Carmichael, S. L., Shaw, G. M., Laurent, C., Croughan, M. S., & Olney, R. S. (2013). Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatric and Perinatal Epidemiology, 27(4), 353–359.

Huerta-Alardín, A. L., Varon, J., & Marik, P. E. (2005). Bench-to-bedside review: Rhabdomyolysis — an overview for clinicians. Critical Care, 9(2), 158–169.

Kolon, T. F., Herndon, C. D., Baker, L. A., Baskin, L. S., Baxter, C. G., Cheng, E. Y., … & Barthold, J. S. (2014). Evaluation and treatment of cryptorchidism: AUA guideline. The Journal of Urology, 192(2), 337–345.